Market Overview

UPDATE: JP Morgan Upgrades Aetna to Overweight on Revised Numbers Post Deal Closure

Share:
Related AET
Novocure's Stock Gains 3% As Anthem Now Covers Optune For Its Members
Insurers To Continue Struggling With ACA In 2016
Now Humana Says It Might Bail On ObamaCare (Investor's Business Daily)

JP Morgan raised its rating on Aetna (NYSE: AET) from Neutral to Overweight and increased its price target from $46 to $52.

JP Morgan said, "We are upgrading Aetna to Overweight from Neutral and raising our price target from $46 to $52 on the expectation of upwardly revised numbers post CVH deal closing, AET's below-average reform exposure and most importantly an increasing recognition of the company's ACO positioning. From a catalyst perspective, at next Wednesday's investor day we expect initial 2013 EPS guidance in the $5.40 range (JPM $5.40, consensus $5.51), within the range of investor expectations."

Aetna closed at $43.43 on Thursday.

Latest Ratings for AET

DateFirmActionFromTo
Feb 2016BMO CapitalMaintainsOutperform
Feb 2016JefferiesMaintainsHold
Jan 2016JefferiesDowngradesBuyHold

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (AET)

View Comments and Join the Discussion!

Get Benzinga's Newsletters